Metraipolis › archive › dc_6fb2b668c99a

Sodium-Glucose Cotransporter-2 Inhibitors in Type 2 Diabetes: From Metabolic Mechanisms to International Guidelines — Europe PMC PMID:42193176

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42193176
DOI
10.3390/antiox15050553
License (as archived)
solo-consultazione
Archived
2026-11-03T02:32:37.590Z
SHA-256 of the archived text
ab3a69fb92c551769fc40e8d4e2b982b214daae3801638966b74f641d85446ae
Stable URL of this page
https://metraipolis.com/documento/dc_6fb2b668c99a

How to cite

Sodium-Glucose Cotransporter-2 Inhibitors in Type 2 Diabetes: From Metabolic Mechanisms to International Guidelines — Europe PMC PMID:42193176 — Europe PMC (en), https://europepmc.org/article/MED/42193176 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_6fb2b668c99a (Metraipolis archive dc_6fb2b668c99a, sha256 ab3a69fb92c551769fc40e8d4e2b982b214daae3801638966b74f641d85446ae)
BibTeX
@misc{dc6fb2b668c99a,
  title = {Sodium-Glucose Cotransporter-2 Inhibitors in Type 2 Diabetes: From Metabolic Mechanisms to International Guidelines — Europe PMC PMID:42193176},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42193176},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_6fb2b668c99a; sha256 ab3a69fb92c551769fc40e8d4e2b982b214daae3801638966b74f641d85446ae},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42193176. Agents can read the archived copy with the MCP tool read_document.